Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
VaxEquity Logo
VaxEquity Growth Score
61
CB Rank
114674
Heat Score
67
VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.
Founded
obfuscation
PrivateGrant Cambridge, Massachusetts, United States11-50 vaxequity.com/
Biotechnology
Medical
Therapeutics
Overview

VaxEquity
Total Funding
obfuscation
Growth Score
61
Heat Score
67

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score61
-28 pts
in past quarter
Heat Score 67
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About VaxEquity

CB Rank
114674
VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.
Founded
obfuscation
PrivateGrant Cambridge, Massachusetts, United States11-50 vaxequity.com/
Biotechnology
Medical
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name VaxEquity Ltd.
Operating Status Active
Company Type For Profit
About the Company
VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines. It utilizes saRNA to provide greatly enhanced protein expression, combining better tolerability with slower release and thermostability.
Contact Email info@vaxequity.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant
obfuscation
Grant - VaxEquity Logo
Grant - VaxEquity
1
obfuscation
Innovate UKGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Innovate UK Logo
Innovate UK
Yes
Grant - VaxEquity Logo
Grant - VaxEquity
—
Innovate UK Logo
Innovate UK
Yes
Grant - VaxEquity Logo
Grant - VaxEquity
—
Innovate UK Logo
Innovate UK
Yes
Grant - VaxEquity Logo
Grant - VaxEquity
—
Innovate UK Logo
Innovate UK
Yes
Grant - VaxEquity Logo
Grant - VaxEquity
—
Innovate UK Logo
Innovate UK
Yes
Grant - VaxEquity Logo
Grant - VaxEquity
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Aug 12, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 20, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$167.4KThis year, VaxEquity is projected to spend $167.4K on IT, according to Aberdeen.

Active Website Tech Count

8VaxEquity is actively using 8 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, OpenResty, and  GoDaddy CDN.
Sub-Organizations
Frequently Asked Questions

Where is VaxEquity's headquarters? VaxEquity is located in Cambridge, Massachusetts, United States.Who invested in VaxEquity? VaxEquity has 2 investors including Innovate UK and  Morningside Venture Partners.When was the last funding round for VaxEquity? VaxEquity closed its last funding round on
obfuscation
from a Grant round.Who are VaxEquity's competitors? Alternatives and possible competitors to VaxEquity may include Alnylam Pharmaceuticals, Sanofi, and  Orna Therapeutics.How much funding has VaxEquity raised to date? VaxEquity has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|